News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anika Therapeutics (ANIK) Announces Worldwide Development And Commercialization Partnership With Ortho Neutrogena


10/19/2005 5:11:42 PM

Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the signing of an exclusive worldwide development and commercialization partnership with the Ortho Neutrogena Division of Ortho-McNeil Pharmaceutical, Inc., for its hyaluronic acid (HA) based cosmetic tissue augmentation (CTA) therapy. CTA is under development for the correction of dermal defects such as wrinkles, folds and scars, as well as lip augmentation.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES